Highlights

[CARING] YoY Annualized Quarter Result on 2015-05-31 [#4]

Stock [CARING]: CARING PHARMACY GROUP BHD
Announcement Date 28-Jul-2015
Admission Sponsor -
Sponsor -
Financial Year 31-May-2015
Quarter 31-May-2015  [#4]
Profit Trend QoQ -     -5.75%    YoY -     -14.65%
Quarter Report


View:


Show?  YoY % Horiz. %

Annualized Quarter Result
31/05/18 31/05/17 31/05/16 31/05/15 31/05/14 31/05/13  -  CAGR
Revenue 508,270 459,957 402,569 366,699 338,337 0  -  -
  YoY % 10.50% 14.26% 9.78% 8.38% 0.00% - -
  Horiz. % 150.23% 135.95% 118.98% 108.38% 100.00% - -
PBT 29,566 21,953 12,231 18,499 22,810 0  -  -
  YoY % 34.68% 79.49% -33.88% -18.90% 0.00% - -
  Horiz. % 129.62% 96.24% 53.62% 81.10% 100.00% - -
Tax -6,242 -5,164 -3,680 -5,482 -6,534 0  -  -
  YoY % -20.88% -40.33% 32.87% 16.10% 0.00% - -
  Horiz. % 95.53% 79.03% 56.32% 83.90% 100.00% - -
NP 23,324 16,789 8,551 13,017 16,276 0  -  -
  YoY % 38.92% 96.34% -34.31% -20.02% 0.00% - -
  Horiz. % 143.30% 103.15% 52.54% 79.98% 100.00% - -
NP to SH 18,560 13,130 7,289 12,869 15,078 0  -  -
  YoY % 41.36% 80.13% -43.36% -14.65% 0.00% - -
  Horiz. % 123.09% 87.08% 48.34% 85.35% 100.00% - -
Tax Rate 21.11 % 23.52 % 30.09 % 29.63 % 28.65 % - %  -  % -
  YoY % -10.25% -21.83% 1.55% 3.42% 0.00% - -
  Horiz. % 73.68% 82.09% 105.03% 103.42% 100.00% - -
Total Cost 484,946 443,168 394,018 353,682 322,061 0  -  -
  YoY % 9.43% 12.47% 11.40% 9.82% 0.00% - -
  Horiz. % 150.58% 137.60% 122.34% 109.82% 100.00% - -
Net Worth 143,686 130,623 121,915 119,738 113,207 -  -  -
  YoY % 10.00% 7.14% 1.82% 5.77% 0.00% - -
  Horiz. % 126.92% 115.38% 107.69% 105.77% 100.00% - -
Dividend
31/05/18 31/05/17 31/05/16 31/05/15 31/05/14 31/05/13  -  CAGR
Div 10,885 6,531 3,265 4,354 6,531 -  -  -
  YoY % 66.67% 100.00% -25.00% -33.33% 0.00% - -
  Horiz. % 166.67% 100.00% 50.00% 66.67% 100.00% - -
Div Payout % 58.65 % 49.74 % 44.80 % 33.83 % 43.32 % - %  -  % -
  YoY % 17.91% 11.03% 32.43% -21.91% 0.00% - -
  Horiz. % 135.39% 114.82% 103.42% 78.09% 100.00% - -
Equity
31/05/18 31/05/17 31/05/16 31/05/15 31/05/14 31/05/13  -  CAGR
Net Worth 143,686 130,623 121,915 119,738 113,207 -  -  -
  YoY % 10.00% 7.14% 1.82% 5.77% 0.00% - -
  Horiz. % 126.92% 115.38% 107.69% 105.77% 100.00% - -
NOSH 217,706 217,706 217,706 217,706 217,706 -  -  -
  YoY % 0.00% 0.00% 0.00% 0.00% 0.00% - -
  Horiz. % 100.00% 100.00% 100.00% 100.00% 100.00% - -
Ratio Analysis
31/05/18 31/05/17 31/05/16 31/05/15 31/05/14 31/05/13  -  CAGR
NP Margin 4.59 % 3.65 % 2.12 % 3.55 % 4.81 % - %  -  % -
  YoY % 25.75% 72.17% -40.28% -26.20% 0.00% - -
  Horiz. % 95.43% 75.88% 44.07% 73.80% 100.00% - -
ROE 12.92 % 10.05 % 5.98 % 10.75 % 13.32 % - %  -  % -
  YoY % 28.56% 68.06% -44.37% -19.29% 0.00% - -
  Horiz. % 97.00% 75.45% 44.89% 80.71% 100.00% - -
Per Share
31/05/18 31/05/17 31/05/16 31/05/15 31/05/14 31/05/13  -  CAGR
RPS 233.47 211.27 184.91 168.44 155.41 -  -  -
  YoY % 10.51% 14.26% 9.78% 8.38% 0.00% - -
  Horiz. % 150.23% 135.94% 118.98% 108.38% 100.00% - -
EPS 8.53 6.03 3.35 5.91 7.47 0.00  -  -
  YoY % 41.46% 80.00% -43.32% -20.88% 0.00% - -
  Horiz. % 114.19% 80.72% 44.85% 79.12% 100.00% - -
DPS 5.00 3.00 1.50 2.00 3.00 0.00  -  -
  YoY % 66.67% 100.00% -25.00% -33.33% 0.00% - -
  Horiz. % 166.67% 100.00% 50.00% 66.67% 100.00% - -
NAPS 0.6600 0.6000 0.5600 0.5500 0.5200 0.0000  -  -
  YoY % 10.00% 7.14% 1.82% 5.77% 0.00% - -
  Horiz. % 126.92% 115.38% 107.69% 105.77% 100.00% - -
Adjusted Per Share Value based on latest NOSH - 217,706
31/05/18 31/05/17 31/05/16 31/05/15 31/05/14 31/05/13  -  CAGR
RPS 233.47 211.27 184.91 168.44 155.41 -  -  -
  YoY % 10.51% 14.26% 9.78% 8.38% 0.00% - -
  Horiz. % 150.23% 135.94% 118.98% 108.38% 100.00% - -
EPS 8.53 6.03 3.35 5.91 7.47 0.00  -  -
  YoY % 41.46% 80.00% -43.32% -20.88% 0.00% - -
  Horiz. % 114.19% 80.72% 44.85% 79.12% 100.00% - -
DPS 5.00 3.00 1.50 2.00 3.00 0.00  -  -
  YoY % 66.67% 100.00% -25.00% -33.33% 0.00% - -
  Horiz. % 166.67% 100.00% 50.00% 66.67% 100.00% - -
NAPS 0.6600 0.6000 0.5600 0.5500 0.5200 0.0000  -  -
  YoY % 10.00% 7.14% 1.82% 5.77% 0.00% - -
  Horiz. % 126.92% 115.38% 107.69% 105.77% 100.00% - -
Price Multiplier on Financial Quarter End Date
31/05/18 31/05/17 31/05/16 31/05/15 31/05/14 31/05/13  -  CAGR
Date 31/05/18 31/05/17 31/05/16 29/05/15 30/05/14 -  -  -
Price 1.5500 1.8100 1.7500 1.0000 2.1100 0.0000  -  -
P/RPS 0.66 0.86 0.95 0.59 1.36 0.00  -  -
  YoY % -23.26% -9.47% 61.02% -56.62% 0.00% - -
  Horiz. % 48.53% 63.24% 69.85% 43.38% 100.00% - -
P/EPS 18.18 30.01 52.27 16.92 30.47 0.00  -  -
  YoY % -39.42% -42.59% 208.92% -44.47% 0.00% - -
  Horiz. % 59.67% 98.49% 171.55% 55.53% 100.00% - -
EY 5.50 3.33 1.91 5.91 3.28 0.00  -  -
  YoY % 65.17% 74.35% -67.68% 80.18% 0.00% - -
  Horiz. % 167.68% 101.52% 58.23% 180.18% 100.00% - -
DY 3.23 1.66 0.86 2.00 1.42 0.00  -  -
  YoY % 94.58% 93.02% -57.00% 40.85% 0.00% - -
  Horiz. % 227.46% 116.90% 60.56% 140.85% 100.00% - -
P/NAPS 2.35 3.02 3.13 1.82 4.06 0.00  -  -
  YoY % -22.19% -3.51% 71.98% -55.17% 0.00% - -
  Horiz. % 57.88% 74.38% 77.09% 44.83% 100.00% - -
Price Multiplier on Announcement Date
31/05/18 31/05/17 31/05/16 31/05/15 31/05/14 31/05/13  -  CAGR
Date 24/07/18 27/07/17 29/07/16 28/07/15 31/07/14 -  -  -
Price 1.6500 1.7000 1.6700 1.1000 2.1400 0.0000  -  -
P/RPS 0.71 0.80 0.90 0.65 1.38 0.00  -  -
  YoY % -11.25% -11.11% 38.46% -52.90% 0.00% - -
  Horiz. % 51.45% 57.97% 65.22% 47.10% 100.00% - -
P/EPS 19.35 28.19 49.88 18.61 30.90 0.00  -  -
  YoY % -31.36% -43.48% 168.03% -39.77% 0.00% - -
  Horiz. % 62.62% 91.23% 161.42% 60.23% 100.00% - -
EY 5.17 3.55 2.00 5.37 3.24 0.00  -  -
  YoY % 45.63% 77.50% -62.76% 65.74% 0.00% - -
  Horiz. % 159.57% 109.57% 61.73% 165.74% 100.00% - -
DY 3.03 1.76 0.90 1.82 1.40 0.00  -  -
  YoY % 72.16% 95.56% -50.55% 30.00% 0.00% - -
  Horiz. % 216.43% 125.71% 64.29% 130.00% 100.00% - -
P/NAPS 2.50 2.83 2.98 2.00 4.12 0.00  -  -
  YoY % -11.66% -5.03% 49.00% -51.46% 0.00% - -
  Horiz. % 60.68% 68.69% 72.33% 48.54% 100.00% - -

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.


NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ Δ & YoY Δ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.



  Be the first to like this.
 


APPS
I3 Messenger
Individual or Group chat with anyone on I3investor
MQ Trader
Stock Screener using Technical and Fundamental criteria
MQ Affiliate
Join the MQ Affiliate Program today to earn rewards
 
 

395  610  596  818 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 YONGTAI 0.355+0.06 
 MTRONIC 0.14+0.02 
 HWGB 0.96+0.115 
 MTRONIC-WA 0.09+0.015 
 SAPNRG 0.125+0.005 
 PHB 0.035+0.005 
 EAH 0.03-0.005 
 INIX 0.345+0.08 
 KNM 0.225+0.015 
 KANGER 0.1750.00 

FEATURED POSTS

1. The Equity Market Index Benchmark in Malaysia CMS
2. Trading Scenarios of Derivatives Bursa Derivatives Education Series
3. Derivatives 101 Bursa Derivatives Education Series
4. Why Trade FKLI? Bursa Derivatives Education Series
5. MQ Trader - Introduction to MQ Trader Affiliate Program MQ Trader Announcement!

TOP ARTICLES

1. Vivocom’s V-Shape Recovery still intact, and a sharp rally upwards to RM1.22/RM1.48/RM2.20 can take off anytime See Jovin
2. Vivocom’s Steady and Calm Rally to RM1.12 Today. Will It Surge to Break RM1.22 Soon? See Jovin
3. 商业高峰(PUNCAK,6807)股价低于产值 。。。。 jjjmoney
4. AN UNDISCOVERED GEM UPDATE: NEW HOT HOT SELLING PRODUCT FLYING OFF THE SHELVES !! Chongkh888
5. Shipping out VACCINE timely? Forwarders see their cargo bumped as vaccine shipments take off. gloveharicut
6. TOPGLOV hints HR ministry’s action does not match stated stand gloveharicut
7. Vivocom’s V-Shape Recovery still intact. Rally still ongoing in a calm and steady stair stepped ascension. See Jovin
8. CIMB Retain Add on TOPGLOV; awaiting further updates on Act 446 gloveharicut
PARTNERS & BROKERS